Registering a CAGR of 8.4%, the global choline supplement market size is projected to increase from USD 612.0 million in 2024 to USD 1,367.9 million by 2034. Factors like escalating awareness of the importance of choline on human health and growing emphasis on preventive healthcare will fuel this growth.
Demand remains particularly high for choline bitartrate supplements, rising at 8.2% CAGR. This can be attributed to better absorption, stability, and cost-effectiveness of choline bitartrate. The target segment is poised to account for a value share of 42.0% by 2034.
| Attributes | Key Insights |
|---|---|
| Market Size in 2024 | USD 612.0 million |
| Market Value in 2034 | USD 1,367.9 million |
| CAGR (2024 to 2034) | 8.4% |
Choline supplements are witnessing strong demand, and the trend is set to persist throughout the forecast period. This is attributable to rising consumer preference for choline supplements due to their potential health benefits.
Choline products have the ability to improve brain, heart, and liver health. These supplements provide choline, an essential nutrient that plays a key role in many bodily functions, including cell membrane health, brain function, and liver health.
Growing consumer interest in brain health supplements and other dietary formulations is set to boost sales of choline supplements. Subsequently, escalating demand for choline supplements during pregnancy to ensure proper placental function, brain development, and fetal growth will benefit the market.
It has been observed that choline deficiency during pregnancy can lead to complications like preterm birth and preeclampsia. To counter this, pregnant women are consuming choline products, thereby boosting market growth.
Choline deficiency is also believed to cause fatty liver disease, also known as hepatosteatosis. This is prompting people to invest in choline supplement products, resulting in higher sales.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
Rising consumer focus on brain health and wellness is fueling the demand for choline supplements. Increasing interest in non-GMO specialty supplements to avoid side effects of GMO supplements will boost sales growth.
Gluten-free supplements are gaining traction in the market due to the increased prevalence of gluten intolerance. Subsequently, clean-label choline products derived from natural sources, such as potatoes, peanuts, and sunflower seeds, are gaining popularity.
Several food and beverage manufacturers are incorporating choline into their products to meet growing consumer demand for healthier options. Thus, surging popularity of fortified foods and beverages will create growth opportunities for the choline product market.
The rising geriatric population, coupled with a surge in health problems like dementia and cognitive decline, will benefit the target market. Similarly, rise in research and scientific studies aimed at exploring the role and health benefits of choline will open new growth opportunities.
Global sales of supplements grew at a CAGR of 5.1% from 2019 to 2023. However, a robust CAGR of 8.4% has been predicted for the global choline product industry in the forecast period, displaying a 3.3% spike from the historical growth rate.
Increasing consumer awareness about the health benefits of choline and changing dietary preferences are anticipated to propel global demand for choline supplements. Another prominent growth-shaping factor is the rising incidence of liver diseases like non-alcoholic fatty liver disease (NAFLD).
On the other hand, factors such as low awareness of choline and its benefits, especially in developing and underdeveloped regions, and regulatory changes will limit market growth. To cope with these challenges, key supplement manufacturers are focusing on educating people about the importance of choline on human health.
The table below shows the predicted CAGR of the leading nations. Australia and Germany are set to witness high supplement consumption, recording CAGRs of 7.3% and 6.7%, respectively, through 2034. This can be attributed to rising applications of choline in prenatal nutrition as well as sports nutrition.
| Countries | CAGR (2024 to 2034) |
|---|---|
| United States | 4.8% |
| Germany | 6.7% |
| India | 5.8% |
| Australia | 7.3% |
The United States choline supplement market is poised to attain a valuation of around USD 277.5 million in 2034. It will register steady growth, with sales of rising at 4.8% CAGR throughout the forecast period.
Multiple factors are spurring growth of the choline product industry in the United States. These include growing demand for brain health supplements, a spike in liver and brain diseases, and increasing attention toward fitness and disease prevention.
There is a surging demand for supplements that enhance brain health across the United States, spurred by growing geriatric population and surge in neurological disorders like Alzheimer’s disease. This, in turn, is set to positively impact supplement sales in the nation.
The adoption of a hectic lifestyle is another key factor propelling demand for choline supplements. Similarly, escalating demand for choline-fortified infant formulas will improve the United States market share through 2034.
The choline supplement market in India is anticipated to grow at 5.8% CAGR throughout the forecast period, totaling a valuation of around USD 84.7 million by 2034. This can be attributed to factors like escalating awareness of the choline and surging demand for fortified foods.
The consumption of supplements is increasing steadily in India due to changing lifestyles and growing preference for healthy supplements. The progressive aging of the Indian population and consequential growth of specific health needs will boost growth of the choline supplement market.
Consumers across India are becoming more health conscious, urging them to seek supplements that can improve their health and well-being. This will uplift demand for choline products in the nation through 2034 and beyond.
Leading players operating in India are educating people about the importance of choline on brain and liver health through advertisements and other promotional activities. This is anticipated to improve choline product consumption in the nation.
Germany’s choline supplement market value is set to total around USD 155.8 million by 2034, registering a CAGR of 6.7% throughout the projection period. This can be attributed to factors such as rising incidence of cardiovascular disease and growing emphasis on preventive healthcare.
There is a sharp increase in food supplement launches and consumption amid rising health awareness. According to the German Federal Office of Consumer Protection of Food Safety, around 8,000 new food supplement products were registered in Germany in 2018.
Preventative healthcare trends are gaining momentum across Germany due to rising diseases related to heart, brain, and liver. This, in turn, is projected to fuel demand for choline products as they are essential for enhancing brain and liver health.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
The section below sheds some light on leading segments along with their projected growth rates. Companies can use this information to invest in popular products and forms to solidify their positions in the global choline product industry.
By ingredient type, the choline bitartrate segment is poised to grow at 8.2% CAGR through 2034. Based on form, choline capsules segment will probably account for a revenue share of 67.5% by 2034. By claim, the non-GMO is forecast to record a 5.7% CAGR from 2024 to 2034.
| Top Segment (Ingredient Type) | Choline Bitartrate |
|---|---|
| CAGR (2024 to 2034) | 8.2% |
As per the latest analysis, demand for choline bitartrate-based supplements is forecast to grow at a higher CAGR of 8.2% during the projection period. The target segment will generate a total revenue of around USD 505.7 million by 2034.
Higher bioavailability, affordability, and lower hygroscopicity of choline bitartrate are key factors behind its rising prominence in the market. Similarly, growing prevalence of neurological disorders and cardiovascular diseases is anticipated to boost segment growth.
Choline bitartrate is the most popular form of choline used in dietary supplementation. This can be attributed to its higher bioavailability, cost-effectiveness, and other advantages. It is mostly used to enhance memory and cognitive function.
Just like B vitamins, choline bitartrate plays a key role in maintaining energy levels, improving metabolism, and enhancing brain function. As a result, it is widely used in dietary supplements to help people with choline and vitamin deficiency.
Choline deficiency causes muscle and liver damage. In order to counter this and manage all problems related to choline deficiency, people consume products, especially choline bitartrate supplements. This will continue to boost growth of the target segment through 2034.
| Top Segment (Form) | Capsule |
|---|---|
| CAGR (2024 to 2034) | 6.5% |
Choline capsules are anticipated to remain the most popular form among consumers, with their consumption rising at a CAGR of 6.7% during the assessment period. Revenue generated by the choline capsules segment will total around USD 922.7 million in 2034. This can be attributed to the expediency and adaptability of choline capsules.
Choline capsules offer longer shelf life and stability. As a result, they are gaining wider popularity among people with choline deficiency or people looking to enhance their brain and body functions. The adaptability of capsule forms allows manufacturers to create easily replaceable and accurately measured products, thereby helping them to cater to the growing trend of on-the-go and portion-controlled consumption.
Choline powder and liquid supplements can taste bitter and be difficult to swallow. This also encourages people to opt for choline capsules as they are easy to swallow while masking off the unpleasant taste.
| Top Segment (Claim) | Non-GMO |
|---|---|
| CAGR (2024 to 2034) | 5.7% |
The latest analysis estimates non-GMO segment to thrive at 5.7% CAGR through 2034, totaling a valuation of USD 858.4 million in 2034. It will retain its market dominance, holding a prominent share of 62.8% by 2034. This is attributable to growing consumer preference for non-GMO dietary supplements.
Many consumers consider Non-GMO supplements more natural and safer than GMO ones. As a result, their demand is escalating steadily, and the trend will persist throughout the assessment period.
Factors such as changing lifestyles, increasing aging populations, and growing health problems are anticipated to further boost segment growth. Non-GMO choline products offer multiple health benefits, such as improving brain, heart, and liver health.
Leading manufacturers of supplements are focusing on developing novel solutions in various forms for targeted individuals seeking cognitive enhancement and other benefits. They are marketing their supplements to people interested in health and wellness.
Several players are using celebrity endorsements and social media platforms to promote their products and increase their customer base. Other key market penetration strategies for choline supplement players include partnerships, acquisitions, mergers, distribution agreements, and collaborations.
Recent Developments in the Choline Product Market:
| Attribute | Details |
|---|---|
| Market Size in 2024 | USD 612.0 million |
| Market Forecast Value in 2034 | USD 1,367.9 million |
| Global Growth Rate (2024 to 2034) | 8.4% CAGR |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2024 |
| Market Analysis | Volume (MT) and Value (USD million) |
| Key Regions Covered | Latin America; North America; Europe; East Asia; Middle East & Africa and Oceania; and South Asia |
| Key Countries Covered | United States, Mexico, Canada, Brazil, Chile, Peru, Italy, Argentina, Spain, France, the United Kingdom, Germany, the Netherlands, Belgium, Russia, the Nordic region, Poland, Japan, India, South Korea, China, Malaysia, Thailand, Singapore, Australia, Gulf Cooperation Council countries, Indonesia, New Zealand, Central Africa, and South Africa |
| Key Market Segments Covered | Ingredient Type, Claim, Sales Channel, Form, and Region |
| Key Companies Profiled | NOW Foods; Country Life Vitamins; Nested Naturals; Spring Valley; Solgar (Nestlé); Vitacost; PERQUE Integrative Health; Bestvite; Vitality Nutritionals; UMZU; NusaPure; Nature's Way Products; Country Life Vitamins; The Vitamin Shoppe; Standard Process; Metabolics; Jarrow Formulas; Solaray |
The global market value is set to total USD 612.0 million in 2024.
The global market size is forecast to reach USD 1,367.9 million by 2034.
Global demand is predicted to rise at 8.4% CAGR through 2034.
NOW Foods, Nature's Way, Products, Nested Naturals, Spring Valley, and Solgar (Nestlé).
Choline bitartrate and phosphatidylcholine citicoline are best forms of choline to take.
Yes, these supplements are widely available.
| Estimated Industry Size (2024E) | USD 9.1 billion |
|---|---|
| Projected Industry Value (2034F) | USD 17.7 billion |
| Value-based CAGR (2024 to 2034) | 13.7 % |
| Estimated Market Size (2024E) | USD 74.3 billion |
|---|---|
| Projected Market Valuation (2034F) | USD 170.1 billion |
| Value-based CAGR (2024 to 2034) | 9.5% |
| Market Size in 2023 | USD 17,160 million |
|---|---|
| Market Forecast in 2033 | USD 29,648.6 million |
| Market CAGR (2023 to 2033) | 6% |
| Market Size (2023E) | USD 1,327 million |
|---|---|
| Market Projected Size (2033F) | USD 2,332 million |
| Value CAGR (2023 to 2033) | 5.8% |
Explore Food Supplement and Nutrition Insights
View Reports
Choline Supplement Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
